You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

checkpoint inhibitor therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastrointestinal Tumor Trial in Hangzhou (Water-filtered infrared A radiation whole-body hyperthermia (HECKEL 3000MT-4T,

Completed
  • Gastrointestinal Tumor
  • Water-filtered infrared A radiation whole-body hyperthermia (HECKEL 3000MT-4T, Germany)
  • tislelizumab (BeiGene, China) combined with PD-1 inhibitor
  • Hangzhou, China
    Zhejiang Hospital
Sep 1, 2023

Determine Pro-Inflammatory Cytokine Kinetics During Immune

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Melanoma
    • Indianapolis, Indiana
      Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
    Jan 30, 2023

    Gut and Tumor Microbiome in Advanced ER-positive and

    Not yet recruiting
    • Breast Cancer
    • Melanoma
    • Observation
    • (no location specified)
    Nov 6, 2023

    Cancer Trial in Rochester (PET/CT)

    Completed
    • Cancer
    • PET/CT
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Aug 3, 2022

    Metastatic Melanoma, Advanced Melanoma Trial in San Francisco (XmAb22841, XmAb23104)

    Not yet recruiting
    • Metastatic Melanoma
    • Advanced Melanoma
    • San Francisco, California
      University of California, San Francisco
    Jan 13, 2023

    Quality of Life and Physical Fitness After Immune Checkpoint

    Completed
    • Melanoma
    • Non Small Cell Lung Cancer
      • Groningen, Netherlands
        University Medical Center Groningen
      Jan 3, 2023

      Immune-Mediated Colitis Trial in Montreal (Tofacitinib 10 mg)

      Recruiting
      • Immune-Mediated Colitis
      • Tofacitinib 10 mg
      • Montreal, Quebec, Canada
        Sir Mortimer B Davis Jewish General Hospital - CIUSSS Centre-Oue
      May 11, 2022

      The Gut Microbiome and Immune Checkpoint Inhibitor Therapy in

      Recruiting
      • Non-Small-Cell Lung Carcinoma
      • +3 more
      • Checkpoint Inhibitor, Immune
      • Elizabethtown, Kentucky
        Baptist Health Clinical Research
      Apr 25, 2022

      Cancer, Fecal Microbiota Transplantation, Immune Checkpoint Inhibitors Trial in Zurich (Fecal Microbiota Transplantation (FMT))

      Recruiting
      • Cancer
      • +2 more
      • Fecal Microbiota Transplantation (FMT)
      • Zurich, Switzerland
        University of Zurich, University Hospital Zurich
      Jun 14, 2022

      Non Small Cell Lung Cancer Trial in Montréal (increasing total fiber intake)

      Not yet recruiting
      • Non Small Cell Lung Cancer
      • increasing total fiber intake
      • Montréal, Quebec, Canada
        Centre hospitalier de l'Université de Montréal (CHUM)
      Apr 6, 2023

      NSCLC Stage IV Trial in Gauting (combination regimen tremelimumab /durvalumab, platinum-based chemo (SoC))

      Withdrawn
      • NSCLC Stage IV
      • combination regimen tremelimumab /durvalumab
      • platinum-based chemotherapy (SoC)
      • Gauting, Germany
        Asklepios Fachkliniken München-Gauting
      Sep 26, 2022

      The Gut Immune System During Immune Checkpoint Inhibitor Therapy

      Recruiting
      • Cancer
      • sigmoidoscopies and and venous blood sampling
      • Groningen, Netherlands
        University Medical Center Groningen
      Jan 4, 2022

      Melanoma Trial in London, Manchester (Nivolumab, Ipilimumab, IMM-101)

      Completed
      • Melanoma
      • London, United Kingdom
      • +1 more
      Apr 6, 2022

      Immune Checkpoint Inhibitor Therapy on Type 2 Inflammation

      Completed
      • Patients Recieving Anti-PD-1 or Anti-PD-L1 Immunotherapies
      • Anti-PD-1 or anti-PD-L1
      • Montpellier, France
        UH Montpellier
      Dec 22, 2021

      Immune Checkpoint Inhibitor Monotherapy or Combined With

      Not yet recruiting
      • Immune Checkpoint Inhibitor Monotherapy or Combined With Molecular Targeting Drugs / Locoregional Therapy for Hepatocellular Carcinoma
      • Immune checkpoint inhibitor
      • Guangzhou, Guangdong, China
        Department of Minimally Invasive and Interventional Radiology, L
      Jan 30, 2023

      Metastatic Melanoma, Skin Cancer Trial in Boston (Ipilimumab, Nivolumab, Cryoablation)

      Not yet recruiting
      • Metastatic Melanoma
      • Skin Cancer
      • Boston, Massachusetts
        Massachusetts General Hospital Cancer Center
      Mar 9, 2023

      Carcinoma, Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma Trial (NRC-2694-A, Paclitaxel)

      Recruiting
      • Carcinoma
      • Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
      • Los Angeles, California
      • +2 more
      Nov 23, 2022

      Healthcare Resource Utilization and Costs of Immune Checkpoint

      Completed
      • Melanoma
        • East Hanover, New Jersey
          Novartis
        May 12, 2023

        Nasopharyngeal Carcinoma, Immune Checkpoint Inhibitor, Radiotherapy Trial (radiation, drug, biological)

        Not yet recruiting
        • Nasopharyngeal Carcinoma
        • +3 more
        • Intensity Modulated Radiation Therapy
        • +3 more
        • (no location specified)
        Jul 11, 2023

        Metastatic Pancreatic Cancer Trial in Rotterdam (Durvalumab, Rintatolimod)

        Not yet recruiting
        • Metastatic Pancreatic Cancer
        • Durvalumab
        • Rintatolimod
        • Rotterdam, Zuid-Holland, Netherlands
          Erasmus MC
        Jun 23, 2023

        Immune-related Colitis, Colitis Trial in Minneapolis (RMT, Placebo)

        Not yet recruiting
        • Immune-related Colitis
        • Colitis
        • Minneapolis, Minnesota
          University of Minnesota
        Feb 4, 2023

        Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Trial

        Not yet recruiting
        • Anatomic Stage I Breast Cancer AJCC v8
        • +3 more
        • Pembrolizumab
        • +5 more
        • (no location specified)
        Apr 12, 2023

        Adverse Events-related Healthcare Resource Utilization and Costs

        Completed
        • Melanoma
        • East Hanover, New Jersey
          Novartis Pharmaceuticals
        Jan 27, 2023

        Correlate Tracer Uptake to TCell Tumor Infiltration & CkIT Benefit Trial in Stanford, Portland ([18F]F-AraG)

        Not yet recruiting
        • Solid Tumor
        • Fluorine F 18 Ara-G
        • Palo Alto, California
          Stanford University
        Feb 1, 2022

        Gastrointestinal Cancer Trial in New York, Providence (Cobimetinib, Hydroxychloroquine, Atezolizumab)

        Active, not recruiting
        • Gastrointestinal Cancer
        • New York, New York
        • +1 more
        Nov 29, 2022